Cargando…
SARS-CoV-2 getting into the brain; neurological phenotype of COVID-19, and management by nano-biotechnology
Autores principales: | Kujawska, Małgorzata, Mostafavi, Ebrahim, Kaushik, Ajeet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727447/ https://www.ncbi.nlm.nih.gov/pubmed/36018157 http://dx.doi.org/10.4103/1673-5374.346486 |
Ejemplares similares
-
Exploring magneto-electric nanoparticles (MENPs): a platform for implanted deep brain stimulation
por: Kujawska, Małgorzata, et al.
Publicado: (2022) -
SARS‐CoV‐2 Omicron variant: A next phase of the COVID‐19 pandemic and a call to arms for system sciences and precision medicine
por: Mostafavi, Ebrahim, et al.
Publicado: (2022) -
To manage long COVID by selective SARS-CoV-2 infection biosensing
por: Kaushik, Ajeet, et al.
Publicado: (2022) -
Advancements in nano-enabled therapeutics for neuroHIV management
por: Kaushik, Ajeet, et al.
Publicado: (2016) -
Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers
por: Rello, Jordi, et al.
Publicado: (2020)